You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
It is possible that some of the products on the other site are not approved in the Indian Subcontinent.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Medtronic spinal cord stimulation (SCS) offers a non-opioid alternative when other chronic pain treatments have failed, such as:
SCS disrupts the pain signals traveling between the spinal cord and the brain. Stimulation is delivered by a neurostimulator — a device similar to a pacemaker — implanted under the skin.
The impulses travel from the device to the spine over thin insulated wires called leads.
Multiple clinical studies have shown the long-term effectiveness of SCS for chronic pain. Medtronic SCS therapy using the Intellis™ SCS system may give you both pain relief and improved function. In fact, patients in the Vectors Study* using the Intellis™ system reported the following results:1-4
79% experienced a clinically significant reduction in overall, back and/or leg pain at 12 months
70% achieved a personal activity goal by three months after implant
85% were satisfied with SCS therapy at 12 months
92% would recommend SCS therapy to others at three months after implant
Vectors was a study of SCS with a defined clinical protocol. Outcomes of 98 patients were evaluated at 3 months after implant, 96 at six months and 91 at 12 months with a Medtronic Intellis™ system. Patient experience may vary from clinical study results.
Under specific conditions. Talk to your doctor and refer to product labeling for full list of conditions.
Fishman M, Mangal V, Hatheway J, et al. High dose (HD) and Low dose (LD) spinal cord stimulation (SCS) for the effective treatment of chronic back and leg pain: improvements in function. Poster presented at: American Society of Interventional Pain Physicians Annual Meeting. May 3-5, 2019; Las Vegas, NV.
Hatheway J, Fishman M, Mangal V et al. Vectors Post Market Study: Functional outcomes using spinal cord stimulation with high dose stimulation parameters. Presentation at NANS 2020, Las Vegas, Nevada.
Weaver T, Hatheway J, Fishman M et al. Vectors Post Market Study: Subject activity goals and satisfaction with spinal cord stimulation through 3 months. Presentation at NANS 2020, Las Vegas, Nevada.
Fishman M, Davies L, Stromberg K et al. Vectors Post Market Study: SCS (HD) trialing duration and 12-Month Pain Relief following trial success. Presentation at NANS 2020, Las Vegas, Nevada.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.